Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by SinoMab BioScience Limited

SinoMab Awarded the "Most Valuable Pharmaceutical and Medical Company" in the Selection of the "7th Hong Kong Golden Stocks Awards"
From SinoMab BioScience Limited
Via ACN Newswire
IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Approved by FDA
From SinoMab BioScience Limited
Via ACN Newswire
IND Application for SinoMab's First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA
From SinoMab BioScience Limited
Via ACN Newswire
SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
From SinoMab BioScience Limited
Via ACN Newswire
SinoMab Awared the "Best Small and Mid-Cap Company" and "Best CEO" in the Selection of the "6th Hong Kong Golden Stocks Awards" and the "Listed Company with the Most Growth Potential" in the Selection of "2021 Sina Finance Golden Unicorn Best Hong Kong
From SinoMab BioScience Limited
Via ACN Newswire
SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03
From SinoMab BioScience Limited
Via ACN Newswire
SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health
From SinoMab BioScience Limited
Via ACN Newswire
SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases
From SinoMab BioScience Limited
Via ACN Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.